As of Apr 24
| -0.26 / -2.69%|
The 7 analysts offering 12-month price forecasts for Cardiome Pharma Corp have a median target of 12.50, with a high estimate of 15.00 and a low estimate of 5.00. The median estimate represents a +32.98% increase from the last price of 9.40.
The current consensus among 7 polled investment analysts is to Buy stock in Cardiome Pharma Corp. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.